| ARTICLE |
|
|
|
|
|
| Year : 1998 | Volume
: 40
| Issue : 1 | Page : 60-66 |
Active Platelet 5-HT Uptake in Depressives Treated with Impramine and ECT
PK Dalal1, Narottam Lal2, JK Trivedi2, PK Seth3, AK Agarwal4, Abdul Khalid5
1 Associate Professor, Department Psychiatry, K.G.'s Medical College, Lucknow, India
2 Professor, Department Psychiatry, K.G.'s Medical College, Lucknow, India
3 Director, Industrial Toxicology Research Centre, Lucknow, India
4 Scientist, Industrial Toxicology Research Centre, Lucknow, India
5 Ex- Senior Resident, Department Psychiatry, K.G.'s Medical College, Lucknow, India
Correspondence Address:
P K Dalal
Associate Professor, Department Psychiatry, K.G.'s Medical College, Lucknow
India
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 21494445 
Several studies have reported decreased platelet 5-HT uptake in patients of major depression. The present study was undertaken with the aim to study the active platelet 5-HT uptake in depressed patients and effect of treatment with imipramine/ECT on platelet 5-HT uptake in these patients. 30 patients of major depression and equal number of age and sex-matched controls were included in the study. The depressives received imipramine (N=15) or ECT (N=15). Pretreatment active platelet 5-HT uptake was lower in depressives. Treatment with imipramine resulted in significant decrease in 5-HT uptake while with ECT there was significant increase. The serotonergic mechanisms are discussed.
[PDF]*
|
